Publikationen

Eine vollständige Liste der Publikationen unserer Forscher.

973 Publikationen

2024Antimicrob Agents Chemother

Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets

S Haid, A Matthaei, M Winkler, S M Sake, A P Gunesch, V Milke, N M Köhler, J Rückert, G Vieyres, D Kühl, T T Nguyen, M Göhl, L Lasswitz, F J Zapatero-Belinchón, G Brogden, G Gerold, B Wiegmann, U Bilitewski, R J P Brown, M Brönstrup, T F Schulz, T Pietschmann

2024Nat Commun

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor

S M Sake, X Zhang, M K Rajak, M Urbanek-Quaing, A Carpentier, A P Gunesch, C Grethe, A Matthaei, J Rückert, M Galloux, T Larcher, R Le Goffic, F Hontonnou, A K Chatterjee, K Johnson, K Morwood, K Rox, W A M Elgaher, J Huang, M Wetzke, G Hansen, N Fischer, Eleouet J F, M A Rameix-Welti, A K H Hirsch, E Herold, M Empting, C Lauber, T F Schulz, T Krey, S Haid, T Pietschmann

2024J Med Virol

Innate immune response to SARS‐CoV‐2 infection contributes to neuronal damage in human iPSC‐derived peripheral neurons

V Passos, L M Henkel, J Wang, F J Zapatero‐Belinchón, R Möller, G Sun, I Waltl, T Schneider, A Wachs, B Ritter, K A Kropp, S Zhu, M Deleidi, U Kalinke, T F Schulz, G Höglinger, G Gerold, F Wegner, A Viejo‐Borbolla

2024Nat Commun

Anti-CRISPR Anopheles mosquitoes inhibit gene drive spread under challenging behavioural conditions in large cages

R D'Amato, C Taxiarchi, M Galardini, A Trusso, R L Minuz, S Grilli, A G T Somerville, D Shittu, A S Khalil, R Galizi, A Crisanti, A Simoni, R Müller

2024Microbiol Spectr

Landscape of protein-protein interactions during hepatitis C virus assembly and release

A Matthaei, S Joecks, A Frauenstein, J Bruening, D Bankwitz, M Friesland, G Gerold, G Vieyres, L Kaderali, F Meissner, T Pietschmann

2024Clin Immunol

A tetravalent bispecific antibody outperforms the combination of its parental antibodies and neutralizes diverse SARS-CoV-2 variants

A Chiyyeadu, G Asgedom, M Bruhn, C Rocha, T U Schlegel, T Neumann, M Galla, P V Barbosa, M Hoffmann, K Ehrhardt, T C Ha, M Morgan, C T Schoeder, S Pöhlmann, U Kalinke, A Schambach

2023Sci Rep

Seropositivity of Borrelia burgdorferi s.l. in Germany---an analysis across four German National Cohort (NAKO) study sites

M J Hassenstein, T Pischon, A Karch, A Peters, T Kerrinnes, H Teismann, A Schneider, S Thierry, I Moreno Velasquez, J Janke, Y Kemmling, S Castell

2024Immunity

Tissue factor binds to and inhibits interferon-α receptor 1 signaling

J Manoharan, R Rana, G Kuenze, D Gupta, A Elwakiel, S Ambreen, H Wang, K Banerjee, S Zimmermann, K Singh, A Gupta, S Fatima, S Kretschmer, L Schaefer, J Zeng-Brouwers, C Schwab, M M Al-Dabet, I Gadi, H Altmann, T Koch, D M Poitz, R Baber, S Kohli, K Shahzad, R Geffers, M A Lee-Kirsch, U Kalinke, J Meiler, N Mackman, B Isermann

2023RMD Open

Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in PEPD

F Atschekzei, M Fedchenko, A Elsayed, N Dubrowinskaja, T Graalmann, F C Ringshausen, T Witte, G Sogkas

2023BMC Public Health

Association of known SARS-CoV-2 serostatus and adherence to personal protection measures and the impact of personal protective measures on seropositivity in a population-based cross-sectional study (MuSPAD) in Germany

R Kettlitz, M Harries, J Ortmann, G Krause, Spad Team Mu, A Aigner, B Lange